3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Carcinoma, Hepatocellular
2
Solid Cancers
1
Liver Cirrhosis
1
Hepatitis D
1
Hepatitis B
1
Fibrosis
1
Esophageal and Gastric Varices
1
Carcinoma, Renal Cell
1
Interventions
peginterferon alfa-2a
1
menatetrenone
1
lenvatinib
1
human papillomavirus vaccine, L1 type 16, 18
1
Tenofovir
1
Sorafenib
1
PHY 906
1
Engerix-B
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Hepatitis B
×
peginterferon alfa-2a
×
Clear all
NCT05683548
2025-02-17
RCAP
Replicor Inc.
No longer available